Article

HER2 Phenotyping of CTCs By Peptide-Functionalized Nanoparticles As The Diagnostic Biomarkers of Anti-HER2 Treatment in Breast Cancer

2021-05-17

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>The efficacy of anti-human epidermal growth factor receptor 2 (HER2/<italic>neu</italic>) treatment is impacted by tissue-based evaluation bias due to tumor heterogeneity and dynamic changes of HER2 in breast cancer. Circulating tumor cell (CTC)-based HER2 phenotyping provides an integral and real-time assessment, benefiting accurate HER2 diagnosis for improved...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 298ce2ac-ee9b-52f8-a81c-28dbc3b554e2
DOI: 10.21203/rs.3.rs-504941/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HER2 Phenotyping of CTCs By Peptide-Functionalized Nanoparticles As The Diagnostic Biomarkers of Anti-HER2 Treatment in Breast CancerDOI 10.21203/rs.3.rs-504941/v1Read

Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel ApproachSemantic proximity Read

Whole Genome Sequencing in single CTC improves clinical outcome in Her-2 negative breast cancer patientsSemantic proximity Read

Single HER2-Positive Tumor Cells are Detected in Initially HER2-Negative Breast Carcinomas using the DEPArray™–HER2-FISH WorkflowSemantic proximity Read

Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and BloodSemantic proximity Read

Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer.Semantic proximity Read

Circulating CD8+ T-cell repertoires reveal the biological characteristics of tumors and clinical responses to chemotherapy in breast cancer patientsSemantic proximity Read

Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancerSemantic proximity Read

Profiling protein expression in circulating tumour cells using microfluidic western blottingSemantic proximity Read

A novel electrochemiluminescent cytosensor using dual-target magnetic probe recognition and nanozymes-catalyzed cascade signal amplification for precise phenotypic enumeration of CTCsSemantic proximity Read

Immunoengineered magnetic-quantum dot nanobead system for the isolation and detection of circulating tumor cellsSemantic proximity Read

Accurate Isolation of Circulating Tumor Cells via a Heterovalent DNA Framework Recognition Element-Functionalized Microfluidic ChipSemantic proximity Read

EGFR Expression in HER2-Driven Breast Cancer CellsSemantic proximity Read